MedPath

A study of the effectiveness of intranasal ketamine in the treatment of moderate to severe pain in the emergency department

Phase 4
Completed
Conditions
acute pain
Injuries and Accidents - Other injuries and accidents
Anaesthesiology - Pain management
Registration Number
ACTRN12611001102965
Lead Sponsor
Southern Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

Age greater than or equal to 18 years of age

Self-report pain severity as being greater than or equal to 6 on the standard 11-point verbal rating scale (0 = none, 10 = worst pain imaginable)

Medical recommendation for parenteral analgesia (attending doctor’s discretion)

Pain from any cause other than the 3 specific exclusions (see below)

Exclusion Criteria

Known current pregnancy or patient suspects that might be pregnant at time of presentation or female of child-bearing age and not using any form of contraception.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean change in Visual Analog Scale pain score from pre-administration (T0) to 30 minutes post-administration (T30)[30 minutes post-administration of ketamine]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath